AIM IMMUNOTECH INC. Convertible Notes Payable
AIM IMMUNOTECH INC. (AIM) had Convertible Notes Payable of $2.29 million as of 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:ConvertibleNotesPayable · last filed 2020-03-30
- 2019-09-30: Convertible Notes Payable $2.29M.
- 2019-06-30: Convertible Notes Payable $2.28M.
- 2018-12-31: Convertible Notes Payable $3.41M.
- 2018-09-30: Convertible Notes Payable $3.39M.
| Period end | Convertible Notes Payable |
|---|---|
| 2019-09-30 | $2.29M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $2.28M 10-Q · filed 2019-08-14 |
| 2018-12-31 | $3.41M 10-K · filed 2020-03-30 |
| 2018-09-30 | $3.39M 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |